In the ATTAIN-2 trial (participants with obesity and type 2 diabetes), GI adverse event rates were somewhat higher than in ATTAIN-1: nausea 20.1-36.4% versus 8.4% with placebo, vomiting 12.8-23.1% versus 3.8%, diarrhea 21.3-27.4% versus 15.0%, and constipation 17.7-22.4% versus 7.8%
Acidic glutathione S-transferases of rat testis [PMID: 4052031] Laboratory literature summary: Acidic glutathione S-transferases of rat testis
These types of fat are linked to metabolic health, which is why weight loss is not only about looking slimmer
Saxenda (liraglutide) Drug class: GLP-1 Agonists What is Saxenda
A legitimate program will name a state-licensed 503(a) compounding facility or 503B outsourcing facility
While we understand that off-label prescribing can be beneficial in some circumstances, we cannot support it when it is directly contributing to ongoing shortages for those people living with type 2 diabetes and the impact this has on managing it well